Revenue
Breakdown
Segments
Anaptys Bio Generated Anti PD1Jemperli DostarlimabView metric
LicenseView metric
Transaction ServiceView metric
| Segment | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Anaptys Bio Generated Anti PD1Jemperli Dostarlimab | $93M | $15M | $25M | $0 | $133M | $50M | $75M | $258M |
| Transaction Service | — | — | — | $100K | $100K | $100K | — | $100K |
| License | — | — | — | $9.6M | $0 | $0 | $0 | $0 |
| Total | $7.18M | $30.02M | $43.11M | $27.77M | $22.26M | $76.32M | $108.25M | $25.56M |